The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Phase I clinical trials attrition related to central molecular prescreening.
Valentina Boni
No relevant relationships to disclose
Elena Garralda
No relevant relationships to disclose
Antonio Cubillo
No relevant relationships to disclose
Ivan Diaz-Padilla
No relevant relationships to disclose
Antonio Calles
No relevant relationships to disclose
Carlos Gomez-Martin
No relevant relationships to disclose
Sara Cerdá
No relevant relationships to disclose
Sonia Puerta
No relevant relationships to disclose
Esther Ordonez
No relevant relationships to disclose
Fernando López-Ríos
No relevant relationships to disclose
David Olmos
No relevant relationships to disclose
Manuel Hidalgo
No relevant relationships to disclose
Emiliano Calvo
No relevant relationships to disclose